Spotlight Innovation Inc. identifies and acquires rights to innovative, proprietary technologies designed to address unmet medical needs, with an emphasis on rare, emerging and neglected diseases.
Cancer
| BIOTECHNOLOGY | INDICATIONS | MECHANISM OF ACTION |
|---|---|---|
| Crotoxin | Solid cancers (melanoma, breast cancer and non-small cell lung cancer) | Attacks cell membrane and triggers apoptosis (cell death). The compound also provides analgesic effects. Operates as a single product therapeutic. |
| Immunoplex™ | • Breast cancer • Melanoma • Pancreatic cancer • Non-small cell lung cancer | Immune complexes are recognized by Antigen Presenting Cells (APCs) through antibody-specific receptors called Fc Receptors. The immune complexes stimulate APCs that then subsume the immune complexes. The APCs use the subsumed material to educate the adaptive arm of the immune response (T and B cells) to attack the disease-related antigens. |
Read more about the Immunoplex immunotherapy biotechnology
Cancer Imaging
| BIOTECHNOLOGY | INDICATIONS | MECHANISM OF ACTION |
|---|---|---|
| Crotamine (Being developed in cooperation with Emory University) | Cancer diagnostics (imaging, location, staging/metastasis, etc.) | When administered, Crotamine naturally seeks out and enters malignant cells, signaling the location, size and status of the tumor. |